Cargando…

Biochemical and Functional Comparisons of mdx and Sgcg (−/−) Muscular Dystrophy Mouse Models

Mouse models have provided an essential platform to investigate facets of human diseases, from etiology, diagnosis, and prognosis, to potential treatments. Muscular dystrophy (MD) is the most common human genetic disease occurring in approximately 1 in 2500 births. The mdx mouse, which is dystrophin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberts, Nathan W., Holley-Cuthrell, Jenan, Gonzalez-Vega, Magdalis, Mull, Aaron J., Heydemann, Ahlke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433636/ https://www.ncbi.nlm.nih.gov/pubmed/26064876 http://dx.doi.org/10.1155/2015/131436

Ejemplares similares

The superhealing MRL background improves muscular dystrophy
por: Heydemann, Ahlke, et al.
Publicado: (2012)

Increased AMP‐activated protein kinase in skeletal muscles of Murphy Roth Large mice and its potential role in altered metabolism
por: Berhanu, Tirsit K., et al.
Publicado: (2014)

Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling
por: Roberts, Nathan W., et al.
Publicado: (2015)

Intraosseous transplant of dystrophin expressing chimeric (DEC) cells improves skeletal muscle function in mdx mouse model of Duchenne muscular dystrophy
por: Malik, Mohammad, et al.
Publicado: (2021)

Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy—Implications for Therapies
por: Heydemann, Ahlke
Publicado: (2018)

A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies
por: Heydemann, Ahlke, et al.
Publicado: (2023)

Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Siemionow, Maria, et al.
Publicado: (2019)

Moderate exercise improves function and increases adiponectin in the mdx mouse model of muscular dystrophy
por: Zelikovich, Aaron S., et al.
Publicado: (2019)

Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy
por: Siemionow, Maria, et al.
Publicado: (2018)

Disease course in mdx:utrophin(+/−) mice: comparison of three mouse models of Duchenne muscular dystrophy
por: McDonald, Abby A, et al.
Publicado: (2015)

In vivo MRI Characterization of Progressive Cardiac Dysfunction in the mdx Mouse Model of Muscular Dystrophy
por: Stuckey, Daniel J., et al.
Publicado: (2012)

Ventilatory Chemosensory Drive Is Blunted in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2013)

Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
por: Duddy, William, et al.
Publicado: (2015)

Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy
por: van Putten, Maaike, et al.
Publicado: (2019)

In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy
por: Stay, Trace L., et al.
Publicado: (2019)

Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy
por: Saoudi, Amel, et al.
Publicado: (2021)

Humanization of the mdx Mouse Phenotype for Duchenne Muscular Dystrophy Modeling: A Metabolic Perspective
por: Donen, Graham, et al.
Publicado: (2023)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

uPA deficiency exacerbates muscular dystrophy in MDX mice
por: Suelves, Mònica, et al.
Publicado: (2007)

Social stress is lethal in the mdx model of Duchenne muscular dystrophy
por: Razzoli, Maria, et al.
Publicado: (2020)

Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy
por: Siemionow, Maria, et al.
Publicado: (2021)

A slowly progressive form of limb-girdle muscular dystrophy type 2C associated with founder mutation in the SGCG gene in Puerto Rican Hispanics
por: Al-Zaidy, Samiah A, et al.
Publicado: (2015)

Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy
por: Radley-Crabb, Hannah G., et al.
Publicado: (2014)

The Effect of Vitamin D Supplementation on Skeletal Muscle in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Debruin, Danielle A., et al.
Publicado: (2019)

Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy
por: Aranmolate, Azeez, et al.
Publicado: (2017)

Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy
por: Ponzetti, Marco, et al.
Publicado: (2022)

Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy
por: Boccanegra, Brigida, et al.
Publicado: (2023)

Systemically Administered Homing Peptide Targets Dystrophic Lesions and Delivers Transforming Growth Factor-β (TGFβ) Inhibitor to Attenuate Murine Muscular Dystrophy Pathology
por: Iqbal, Aqsa, et al.
Publicado: (2021)

Lack of miR-378 attenuates muscular dystrophy in mdx mice
por: Podkalicka, Paulina, et al.
Publicado: (2020)

Homozygous Inversion on Chromosome 13 Involving SGCG Detected by Short Read Whole Genome Sequencing in a Patient Suffering from Limb-Girdle Muscular Dystrophy
por: Pluta, Natalie, et al.
Publicado: (2022)

Targeted next‐generation sequencing determined a novel SGCG variant that is associated with limb‐girdle muscular dystrophy type 2C: A case report
por: Tran, Nam‐Chung, et al.
Publicado: (2023)

Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model
por: Siemionow, Maria, et al.
Publicado: (2022)

Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy
por: Siemionow, Maria, et al.
Publicado: (2022)

Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients
por: Hyzewicz, Janek, et al.
Publicado: (2015)

Applications of metabolomics and proteomics to the mdx mouse model of Duchenne muscular dystrophy: lessons from downstream of the transcriptome
por: Griffin, Julian L, et al.
Publicado: (2009)

Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy
por: Miranda, Rubén, et al.
Publicado: (2015)

Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy
por: Bozycki, Lukasz, et al.
Publicado: (2018)

Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy
por: Milad, Nadia, et al.
Publicado: (2017)

Proteomic profiling of liver tissue from the mdx-4cv mouse model of Duchenne muscular dystrophy
por: Murphy, Sandra, et al.
Publicado: (2018)

Assessment of Behavioral Characteristics With Procedures of Minimal Human Interference in the mdx Mouse Model for Duchenne Muscular Dystrophy
por: Engelbeen, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a9m3aduhfj8gv7iv7t7sjsbgma